Comparison of the potency and therapeutic efficacy of the anti-CD7 immunotoxin HB2-saporin constructed with one or two saporin moieties per immunotoxin molecule.

por Flavell, D. J., Boehm, D. A., Noss, A., Flavell, S. U.
Publicado 1997

Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual im...

por Flavell, D J, Boehm, D A, Noss, A, Warnes, S L, Flavell, S U
Publicado 2001

A new algorithm for improving fetal weight estimation from ultrasound data at term

por Siggelkow, W., Schmidt, M., Skala, C., Boehm, D., von Forstner, S., Koelbl, H., Tresch, A.
Publicado 2010

Effectiveness of HB2 (anti-CD7)--saporin immunotoxin in an in vivo model of human T-cell leukaemia developed in severe combined immunodeficient mice.

por Morland, B. J., Barley, J., Boehm, D., Flavell, S. U., Ghaleb, N., Kohler, J. A., Okayama, K., Wilkins, B., Flavell, D. J.
Publicado 1994

Preclinical studies with the anti-CD19-saporin immunotoxin BU12-SAPORIN for the treatment of human-B-cell tumours.

por Flavell, D. J., Flavell, S. U., Boehm, D. A., Emery, L., Noss, A., Ling, N. R., Richardson, P. R., Hardie, D., Wright, D. H.
Publicado 1995